These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 8388496
21. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells. Sugiura M, Imai S, Tokunaga M, Koizumi S, Uchizawa M, Okamoto K, Osato T. Br J Cancer; 1996 Aug; 74(4):625-31. PubMed ID: 8761381 [Abstract] [Full Text] [Related]
22. Comparison of in situ hybridization using different nonisotopic probes for detection of Epstein-Barr virus in nasopharyngeal carcinoma and immunohistochemical correlation with anti-latent membrane protein antibody. Brousset P, Butet V, Chittal S, Selves J, Delsol G. Lab Invest; 1992 Oct; 67(4):457-64. PubMed ID: 1331609 [Abstract] [Full Text] [Related]
23. Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: cell phenotype dependence of virus promoter usage. Kerr BM, Lear AL, Rowe M, Croom-Carter D, Young LS, Rookes SM, Gallimore PH, Rickinson AB. Virology; 1992 Mar; 187(1):189-201. PubMed ID: 1310556 [Abstract] [Full Text] [Related]
24. Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5'-flanking region. Hu LF, Minarovits J, Cao SL, Contreras-Salazar B, Rymo L, Falk K, Klein G, Ernberg I. J Virol; 1991 Mar; 65(3):1558-67. PubMed ID: 1847471 [Abstract] [Full Text] [Related]
25. Isolation and characterization of cDNA clones corresponding to transcripts from the BamHI H and F regions of the Epstein-Barr virus genome. Pfitzner AJ, Tsai EC, Strominger JL, Speck SH. J Virol; 1987 Sep; 61(9):2902-9. PubMed ID: 3039177 [Abstract] [Full Text] [Related]
26. [Analysis of Epstein-Barr virus with BamHI "f" variant and XhoI-loss of LMP1 gene in nasopharyngeal carcinoma]. Han AJ, Zong YS, Zhang M, Cao SM, Lin SX, Liang YJ. Zhonghua Bing Li Xue Za Zhi; 2003 Dec; 32(6):534-8. PubMed ID: 14761599 [Abstract] [Full Text] [Related]
27. EBV gene expression in an NPC-related tumour. Hitt MM, Allday MJ, Hara T, Karran L, Jones MD, Busson P, Tursz T, Ernberg I, Griffin BE. EMBO J; 1989 Sep; 8(9):2639-51. PubMed ID: 2479554 [Abstract] [Full Text] [Related]
28. The Epstein-Barr virus BamHI F promoter is an early lytic promoter: lack of correlation with EBNA 1 gene transcription in group 1 Burkitt's lymphoma cell lines. Schaefer BC, Strominger JL, Speck SH. J Virol; 1995 Aug; 69(8):5039-47. PubMed ID: 7609074 [Abstract] [Full Text] [Related]
31. Relative levels of EBNA1 gene transcripts from the C/W, F and Q promoters in Epstein-Barr virus-transformed lymphoid cells in latent and lytic stages of infection. Zetterberg H, Stenglein M, Jansson A, Ricksten A, Rymo L. J Gen Virol; 1999 Feb; 80 ( Pt 2)():457-466. PubMed ID: 10073708 [Abstract] [Full Text] [Related]
32. Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin. Ramayanti O, Juwana H, Verkuijlen SA, Adham M, Pegtel MD, Greijer AE, Middeldorp JM. Int J Cancer; 2017 Jan 01; 140(1):149-162. PubMed ID: 27600027 [Abstract] [Full Text] [Related]
33. The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity. Chen H, Lee JM, Wang Y, Huang DP, Ambinder RF, Hayward SD. Proc Natl Acad Sci U S A; 1999 Aug 03; 96(16):9339-44. PubMed ID: 10430944 [Abstract] [Full Text] [Related]
34. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma. Verhoeven RJ, Tong S, Zhang G, Zong J, Chen Y, Jin DY, Chen MR, Pan J, Chen H. J Virol; 2016 Jul 15; 90(14):6475-88. PubMed ID: 27147748 [Abstract] [Full Text] [Related]
35. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies. Chang Y, Sheen TS, Lu J, Huang YT, Chen JY, Yang CS, Tsai CH. Lab Invest; 1998 Jun 15; 78(6):715-26. PubMed ID: 9645762 [Abstract] [Full Text] [Related]
36. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes. Rowe M, Lear AL, Croom-Carter D, Davies AH, Rickinson AB. J Virol; 1992 Jan 15; 66(1):122-31. PubMed ID: 1309242 [Abstract] [Full Text] [Related]
37. Gene mapping of an Epstein-Barr virus isolate obtained from a nasopharyngeal carcinoma. Zhang HY, Dangel A, Takimoto T, Glaser R. Intervirology; 1989 Jan 15; 30(1):52-60. PubMed ID: 2542179 [Abstract] [Full Text] [Related]
38. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease. Chiang AK, Tao Q, Srivastava G, Ho FC. Int J Cancer; 1996 Nov 04; 68(3):285-90. PubMed ID: 8903467 [Abstract] [Full Text] [Related]
39. Expression of the complementary-strand transcripts from BamHI-A region of the Epstein-Barr virus genome in various induced virus-carrying B cell lines. Zhang CX, Ooka T. Virology; 1995 Apr 01; 208(1):180-8. PubMed ID: 11831698 [Abstract] [Full Text] [Related]
40. Identification of a promoter for the latent membrane protein 1 gene of Epstein-Barr virus that is specifically activated in human epithelial cells. Chang MH, Ng CK, Lin YJ, Liang CL, Chung PJ, ChenML, Tyan YS, Hsu CY, Shu CH, Chang YS. DNA Cell Biol; 1997 Jul 01; 16(7):829-37. PubMed ID: 9260926 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]